Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) — Stella

View on ClinicalTrials.gov

Recruiting

Back to HCC trials

Trial locations(1 site)

Italy

RCCS "Saverio de Bellis", Castellana Grotte, Bari

Key details

Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Collaborators

Dr. Raffaele Cozzolongo, Dr. Palma Aurelia Iacovazzi

Enrollment target

~60 participants

Started

February 2023

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.